|
⚲
|
| Keyboard |
| Ehrlich Christopher B
✚
|
|
|---|---|
| CIK # | 0001293973 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001293973] | |
| 4 | [0001293973] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2026-01-07 | Grant | 4,530,997 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2025-05-30 | Grant | 61,843 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2025-03-04 | Grant | 119,486 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2025-02-24 | Grant | 1,275,000 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2024-12-02 | Grant | 1,275,000 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2024-09-30 | Disposed to issuer | 572,182 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Series A Convertible Preferred Stock · derivative
|
2024-09-25 | Option exercise | 275 | $1,000.00 | 275,000 |
|
CERO Therapeutics Holdings Inc CERO
Common Stock
|
2024-09-25 | Option exercise | 5,312,983 | ||
|
eFFECTOR Therapeutics Inc EFTR
Stock Option (Right to Buy) · derivative
|
2024-06-13 | Grant | 800 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2024-03-25 | Grant | 572,182 | $0.00 | |
|
eFFECTOR Therapeutics Inc EFTR
Stock Option (Right to Buy) · derivative
|
2024-02-19 | Grant | 2,000 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Common Stock
|
2024-02-14 | Other | 1,125,000 | ||
|
CERO Therapeutics Holdings Inc CERO
Series A Convertible Preferred Stock · derivative
|
2024-02-14 | Grant | 100 | $1,000.00 | 100,000 |
|
CERO Therapeutics Holdings Inc CERO
Convertible Promissory Note · derivative
|
2024-02-14 | Option exercise | 0 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Series A Convertible Preferred Stock · derivative
|
2024-02-14 | Option exercise | 1,555 | $1,000.00 | 1,555,000 |
|
CERO Therapeutics Holdings Inc CERO
Series A Convertible Preferred Stock · derivative
|
2024-02-14 | Other | 1,555 | $1,000.00 | 1,555,000 |
|
CERO Therapeutics Holdings Inc CERO
Series A Convertible Preferred Stock · derivative
|
2024-02-14 | Other | 175 | $1,000.00 | 175,000 |
|
CERO Therapeutics Holdings Inc CERO
Warrants · derivative
|
2024-02-14 | Other | 349,998 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Warrants · derivative
|
2024-02-14 | Other | 5,000 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Common Stock
|
2024-02-14 | Other | 3,600 | ||
| showing 20 of 58 most recent transactions | |||||